113 related articles for article (PubMed ID: 26770724)
41. Antioxidant enzymes GSR, SOD1, SOD2, and CAT gene variants and bone mineral density values in postmenopausal women: a genetic association analysis.
Mlakar SJ; Osredkar J; Prezelj J; Marc J
Menopause; 2012 Mar; 19(3):368-76. PubMed ID: 22089180
[TBL] [Abstract][Full Text] [Related]
42. CD38 is associated with premenopausal and postmenopausal bone mineral density and postmenopausal bone loss.
Drummond FJ; Mackrill JJ; O'sullivan K; Daly M; Shanahan F; Molloy MG
J Bone Miner Metab; 2006; 24(1):28-35. PubMed ID: 16369895
[TBL] [Abstract][Full Text] [Related]
43. The rs1256044 polymorphism in the ESR2 gene and the risk for osteoporosis in Polish postmenopausal women.
Kamiński A; Bogacz A; Czerny B
Gynecol Endocrinol; 2018 Jul; 34(7):579-583. PubMed ID: 29320918
[TBL] [Abstract][Full Text] [Related]
44. The importance of the Wnt/β-catenin pathway and LRP5 protein in bone metabolism of postmenopausal women.
Kamiński A; Karasiewicz M; Bogacz A; Dziekan K; Seremak-Mrozikiewicz A; Czerny B
Adv Clin Exp Med; 2019 Feb; 28(2):179-184. PubMed ID: 29963786
[TBL] [Abstract][Full Text] [Related]
45. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
Brodowska A
Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
[TBL] [Abstract][Full Text] [Related]
46. The effect of A163G polymorphism in the osteoprotegerin gene on osteoporosis related traits in Slovak postmenopausal women.
Krajcovicova V; Omelka R; Durisová J; Martiniakova M; Galbavy D; Bauerova M
Anthropol Anz; 2015; 72(3):311-9. PubMed ID: 26131575
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of eNOS gene polymorphisms in relation to BMD in postmenopausal women.
Firat SC; Cetin Z; Samanci N; Aydin F; Balci N; Gungor F; Firat MZ; Luleci G; Karauzum SB
Maturitas; 2009 Aug; 63(4):352-6. PubMed ID: 19520527
[TBL] [Abstract][Full Text] [Related]
48. Association of the C-509-->T polymorphism, alone of in combination with the T869-->C polymorphism, of the transforming growth factor-beta1 gene with bone mineral density and genetic susceptibility to osteoporosis in Japanese women.
Yamada Y; Miyauchi A; Takagi Y; Tanaka M; Mizuno M; Harada A
J Mol Med (Berl); 2001 Apr; 79(2-3):149-56. PubMed ID: 11357939
[TBL] [Abstract][Full Text] [Related]
49. Bone mass loss is associated with systolic blood pressure in postmenopausal women with type 2 diabetes in Tibet: a retrospective cross-sectional study.
Zhou L; Song J; Yang S; Meng S; Lv X; Yue J; Mina A; Puchi B; Geng Y; Yang L
Osteoporos Int; 2017 May; 28(5):1693-1698. PubMed ID: 28154942
[TBL] [Abstract][Full Text] [Related]
50. Association between VDR ApaI polymorphism and hip bone mineral density can be modified by body mass index: a study on postmenopausal Chinese women.
Xu H; Xiong DH; Xu FH; Zhang YY; Lei SF; Deng HW
Acta Biochim Biophys Sin (Shanghai); 2005 Jan; 37(1):61-7. PubMed ID: 15645083
[TBL] [Abstract][Full Text] [Related]
51. Relation of BsmI vitamin D receptor gene polymorphism to bone mineral density and occurrence of osteoporosis in postmenopausal Chinese women in Taiwan.
Chen HY; Chen WC; Hsu CD; Tsai FJ; Tsai CH; Li CW
Osteoporos Int; 2001 Dec; 12(12):1036-41. PubMed ID: 11846330
[TBL] [Abstract][Full Text] [Related]
52. Polymorphism of vitamin D3 receptor and its relation to mineral bone density in perimenopausal women.
Boroń D; Kamiński A; Kotrych D; Bogacz A; Uzar I; Mrozikiewicz PM; Czerny B
Osteoporos Int; 2015 Mar; 26(3):1045-52. PubMed ID: 25407264
[TBL] [Abstract][Full Text] [Related]
53. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
54. Prediction of bone mineral density from vitamin D receptor polymorphisms is uncertain in representative samples of Japanese Women. The Japanese Population-based Osteoporosis (JPOS) Study.
Morita A; Iki M; Dohi Y; Ikeda Y; Kagamimori S; Kagawa Y; Matsuzaki T; Yoneshima H; Marumo F;
Int J Epidemiol; 2004 Oct; 33(5):979-88. PubMed ID: 15358739
[TBL] [Abstract][Full Text] [Related]
55. Osteoporotic fractures are associated with an 86-base pair repeat polymorphism in the interleukin-1--receptor antagonist gene but not with polymorphisms in the interleukin-1beta gene.
Langdahl BL; Løkke E; Carstens M; Stenkjaer LL; Eriksen EF
J Bone Miner Res; 2000 Mar; 15(3):402-14. PubMed ID: 10750554
[TBL] [Abstract][Full Text] [Related]
56. Osteocalcin HindIII gene polymorphism not associated with bone mineral density—A study in North Indian postmenopausal osteoporotic women.
Ahmad I; Jafar T; Mahdi F; Arshad MD; Das SK; Waliullah S; Rizvi I; Mahdi AA
Indian J Exp Biol; 2016 Nov; 54(11):788-93. PubMed ID: 30179426
[TBL] [Abstract][Full Text] [Related]
57. Prevalence and Risk Factors of Osteoporosis in Postmenopausal Women with Type 2 Diabetes Mellitus.
Raška I; Rašková M; Zikán V; Škrha J
Cent Eur J Public Health; 2017 Mar; 25(1):3-10. PubMed ID: 28399348
[TBL] [Abstract][Full Text] [Related]
58. Association of the I264T variant in the sulfide quinone reductase-like (SQRDL) gene with osteoporosis in Korean postmenopausal women.
Jin HS; Kim J; Park S; Park E; Kim BY; Choi VN; Yoo YH; Kim BT; Jeong SY
PLoS One; 2015; 10(8):e0135285. PubMed ID: 26258864
[TBL] [Abstract][Full Text] [Related]
59. Association of the osteoprotegerin gene polymorphisms with bone mineral density in postmenopausal women.
Arko B; Prezelj J; Kocijancic A; Komel R; Marc J
Maturitas; 2005 Jul; 51(3):270-9. PubMed ID: 15978970
[TBL] [Abstract][Full Text] [Related]
60. Identification of the risk factors for osteoporosis among postmenopausal women.
Demir B; Haberal A; Geyik P; Baskan B; Ozturkoglu E; Karacay O; Deveci S
Maturitas; 2008; 60(3-4):253-6. PubMed ID: 18778903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
